{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:41:11Z","timestamp":1784806871866,"version":"3.55.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.tips.2021.02.001","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T20:16:27Z","timestamp":1616184987000},"page":"316-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Beyond the NFAT Horizon: From Cyclosporine A-Induced Adverse Skin Effects to Novel Therapeutics"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5311-3840","authenticated-orcid":false,"given":"Nathan J.","family":"Hawkshaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Paus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2021.02.001_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01986686","article-title":"Biological effects of cyclosporin A: a new antilymphocytic agent","volume":"43","author":"Borel","year":"1994","journal-title":"Agents Actions"},{"key":"10.1016\/j.tips.2021.02.001_bb0010","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","article-title":"Cyclosporin A in patients receiving renal allografts from cadaver donors","volume":"312","author":"Calne","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2021.02.001_bb0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0031-6997(25)00033-X","article-title":"Pharmacology of cyclosporine (sandimmune). VII. Pathophysiology and toxicology of cyclosporine in humans and animals","volume":"41","author":"Mason","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.tips.2021.02.001_bb0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1572-0241.2007.01718.x","article-title":"Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease","volume":"103","author":"Sternthal","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.tips.2021.02.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb3900","article-title":"A highly potent lymphatic system\u2013targeting nanoparticle cyclosporine prevents glomerulonephritis in mouse model of lupus","volume":"6","author":"Ganugula","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2021.02.001_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2003705","article-title":"Identifying novel strategies for treating human hair loss disorders: cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair follicles","volume":"16","author":"Hawkshaw","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tips.2021.02.001_bb0035","first-page":"365","article-title":"The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration","volume":"60","author":"Paus","year":"1989","journal-title":"Lab. Investig."},{"key":"10.1016\/j.tips.2021.02.001_bb0040","first-page":"1433","article-title":"Hair growth modulation by topical immunophilin ligands: Induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia","volume":"150","author":"Maurer","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tips.2021.02.001_bb0045","doi-asserted-by":"crossref","first-page":"C1593","DOI":"10.1152\/ajpcell.00537.2002","article-title":"Cyclosporin A-induced hair growth in mice is associated with inhibition of calcineurin-dependent activation of NFAT in follicular keratinocytes","volume":"284","author":"Gafter-Gvili","year":"2003","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.tips.2021.02.001_bb0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/0974-7753.96101","article-title":"Cosmetically disfiguring side effects of cyclosporine","volume":"4","author":"Panicker","year":"2012","journal-title":"Int. J. Trichology"},{"key":"10.1016\/j.tips.2021.02.001_bb0055","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00105-008-1489-z","article-title":"Hypertrichose","volume":"59","author":"Tr\u00fceb","year":"2008","journal-title":"Der Hautarzt"},{"key":"10.1016\/j.tips.2021.02.001_bb0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archderm.1987.01660250050016","article-title":"Hair growth in scalp grafts from patients with alopecia areata and alopecia universalis grafted onto nude mice","volume":"123","author":"Gilhar","year":"1987","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0190-9622(90)70033-E","article-title":"Topical cyclosporine in male pattern alopecia","volume":"22","author":"Gilhar","year":"1990","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0070","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2133.1988.tb03501.x","article-title":"The effect of topical cyclosporin on the immediate shedding of human scalp hair grafted onto nude mice","volume":"119","author":"Gilhar","year":"1988","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0075","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/1523-1747.ep12468979","article-title":"Cyclosporin A prolongs human hair growth in vitro","volume":"100","author":"Taylor","year":"1993","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0080","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1038\/jid.2015.121","article-title":"Re-evaluating cyclosporine A as a hair growth-promoting agent in human scalp hair follicles","volume":"135","author":"Hawkshaw","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/1523-1747.ep12392542","article-title":"A murine model for inducing and manipulating hair follicle regression (catagen): effects of dexamethasone and cyclosporin A","volume":"103","author":"Paus","year":"1994","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0090","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/BF02507112","article-title":"Hair growth control by immunosuppression","volume":"288","author":"Paus","year":"1996","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.tips.2021.02.001_bb0095","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM199908123410706","article-title":"The biology of hair follicles","volume":"341","author":"Paus","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2021.02.001_bb0100","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","article-title":"Pathobiology of chemotherapy-induced hair loss","volume":"14","author":"Paus","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.tips.2021.02.001_bb0105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1600-0625.2005.00362.x","article-title":"Learning from nudity: lessons from the nude phenotype","volume":"14","author":"Mecklenburg","year":"2005","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000211097","article-title":"Glucocorticoid effect on hair growth initiation: a reconsideration","volume":"6","author":"Stenn","year":"1993","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.tips.2021.02.001_bb0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1523-1747.1998.00243.x","article-title":"Generation and cyclic remodeling of the hair follicle immune system in mice","volume":"111","author":"Paus","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0120","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1038\/s41467-019-12680-x","article-title":"NFAT primes the human RORC locus for ROR\u03b3t expression in CD4+ T cells","volume":"10","author":"Yahia-Cherbal","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2021.02.001_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017685","article-title":"Expression of a constitutively active calcineurin encoded by an intron-retaining mRNA in follicular keratinocytes","volume":"6","author":"Fujimura","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2021.02.001_bb0130","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2007.11.047","article-title":"NFATc1 balances quiescence and proliferation of skin stem cells","volume":"132","author":"Horsley","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.02.001_bb0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1067\/mjd.2003.100","article-title":"Hypertrichosis","volume":"48","author":"Wendelin","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0625.2009.00935.x","article-title":"The mesenchymal component of hair follicle neogenesis: background, methods and molecular characterization","volume":"19","author":"Ohyama","year":"2010","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0145","doi-asserted-by":"crossref","first-page":"R132","DOI":"10.1016\/j.cub.2008.12.005","article-title":"The hair follicle as a dynamic miniorgan","volume":"19","author":"Schneider","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tips.2021.02.001_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070128","article-title":"Crosstalk between Shh and TGF-\u03b2 signaling in cyclosporine-enhanced cell proliferation in human gingival fibroblasts","volume":"8","author":"Chung","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tips.2021.02.001_bb0155","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/exd.12836","article-title":"Human hair follicle organ culture: theory, application and perspectives","volume":"24","author":"Langan","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.diff.2018.10.002","article-title":"The renaissance of human skin organ culture: a critical reappraisal","volume":"104","author":"Zhou","year":"2018","journal-title":"Differentiation"},{"key":"10.1016\/j.tips.2021.02.001_bb0165","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1038\/s41467-018-05973-0","article-title":"Olfactory receptor OR2AT4 regulates human hair growth","volume":"9","author":"Ch\u00e9ret","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2021.02.001_bb0170","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/bjd.18356","article-title":"Deciphering the molecular morphology of the human hair cycle: Wnt signalling during the telogen\u2013anagen transformation","volume":"182","author":"Hawkshaw","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0175","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.stem.2013.10.003","article-title":"Distinct functions for Wnt\/\u03b2-catenin in hair follicle stem cell proliferation and survival and interfollicular epidermal homeostasis","volume":"13","author":"Choi","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tips.2021.02.001_bb0180","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bone.2009.02.013","article-title":"A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation","volume":"44","author":"Bodine","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.tips.2021.02.001_bb0185","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bjd.19552","article-title":"A novel nondrug SFRP1 antagonist inhibits catagen development in human hair follicles ex vivo","volume":"184","author":"Bertolini","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0190","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1038\/cddis.2013.410","article-title":"Cyclophilin A: a key player for human disease","volume":"4","author":"Nigro","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2021.02.001_bb0195","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1126\/science.6238408","article-title":"Cyclophilin: a specific cytosolic binding protein for cyclosporin A","volume":"226","author":"Handschumacher","year":"1984","journal-title":"Science (80-. )"},{"key":"10.1016\/j.tips.2021.02.001_bb0200","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/337473a0","article-title":"Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin","volume":"337","author":"Takahashi","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.tips.2021.02.001_bb0205","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1677\/joe.1.06685","article-title":"Prolactin delays hair regrowth in mice","volume":"191","author":"Craven","year":"2006","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tips.2021.02.001_bb0210","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tem.2010.06.001","article-title":"Prolactin: an emerging force along the cutaneous\u2013endocrine axis","volume":"21","author":"Langan","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tips.2021.02.001_bb0215","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/jid.2008.348","article-title":"Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone","volume":"129","author":"Foitzik","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0220","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1158\/0008-5472.CAN-08-0639","article-title":"Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer","volume":"68","author":"Zheng","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2021.02.001_bb0225","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2353\/ajpath.2009.080753","article-title":"Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer","volume":"174","author":"Fang","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tips.2021.02.001_bb0230","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1038\/onc.2009.458","article-title":"FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A","volume":"29","author":"Periyasamy","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.tips.2021.02.001_bb0235","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/brv.12579","article-title":"Neuroendocrinology and neurobiology of sebaceous glands","volume":"95","author":"Clayton","year":"2020","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"key":"10.1016\/j.tips.2021.02.001_bb0240","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.molmed.2014.06.002","article-title":"Neuroendocrinology of the hair follicle: principles and clinical perspectives","volume":"20","author":"Paus","year":"2014","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tips.2021.02.001_bb0245","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw4597","article-title":"Inhibition of mitochondrial permeability transition by deletion of the ANT family and CypD","volume":"5","author":"Karch","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2021.02.001_bb0250","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/jid.2010.415","article-title":"Keratinocyte secretion of cyclophilin B via the constitutive pathway is regulated through its cyclosporin-binding site","volume":"131","author":"Fearon","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tcb.2010.09.011","article-title":"Interaction of calcineurin with substrates and targeting proteins","volume":"21","author":"Li","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.tips.2021.02.001_bb0260","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jid.2017.08.042","article-title":"NF-\u03baB participates in mouse hair cycle control and plays distinct roles in the various pelage hair follicle types","volume":"138","author":"Krieger","year":"2018","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0265","doi-asserted-by":"crossref","first-page":"970","DOI":"10.15252\/emmm.201303541","article-title":"Epidermal p65\/NF-\u03baB signalling is essential for skin carcinogenesis","volume":"6","author":"Kim","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.tips.2021.02.001_bb0270","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1038\/ncomms8652","article-title":"NF-\u03baB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis","volume":"6","author":"Yan","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2021.02.001_bb0275","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/jid.2014.82","article-title":"NF-\u03baB activity is required for anagen maintenance in human hair follicles in vitro","volume":"134","author":"Kloepper","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0280","first-page":"237","article-title":"Calcineurin: from structure to function","volume":"36","author":"Aramburu","year":"2000","journal-title":"Curr. Top. Cell. Regul."},{"key":"10.1016\/j.tips.2021.02.001_bb0285","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jid.2018.12.026","article-title":"Topical application of a dual ABC transporter substrate and NF-\u03baB inhibitor blocks multiple sources of cutaneous inflammation in mouse skin","volume":"139","author":"Li","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0290","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tips.2021.02.001_bb0295","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0014-5793(97)00930-7","article-title":"Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-\u03baB activation","volume":"413","author":"Meyer","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tips.2021.02.001_bb0300","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/art.1780390407","article-title":"Activation of the transcription factor nuclear factor-\u03baB in human inflamed synovial tissue","volume":"39","author":"Marok","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.tips.2021.02.001_bb0305","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0016-5085(98)70202-1","article-title":"Nuclear factor \u03baB is activated in macrophages and epithelial cells of inflamed intestinal mucosa","volume":"115","author":"Rogler","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tips.2021.02.001_bb0310","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-2094-9-15","article-title":"Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation","volume":"9","author":"Ellrichmann","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.tips.2021.02.001_bb0315","first-page":"5335","article-title":"lncRNA MALAT1 overexpression promotes proliferation, migration and invasion of gastric cancer by activating the PI3K\/AKT pathway","volume":"17","author":"Zhu","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tips.2021.02.001_bb0320","first-page":"805","article-title":"Long non-coding RNA MALAT1 activates autophagy and promotes cell proliferation by downregulating microRNA-204 expression in gastric cancer","volume":"19","author":"Shao","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.tips.2021.02.001_bb0325","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCRESAHA.119.315856","article-title":"Preclinical and clinical development of noncoding RNA therapeutics for cardiovascular disease","volume":"126","author":"Cheng-Kai","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.tips.2021.02.001_bb0330","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/BF00371743","article-title":"Hair cycle-dependent changes in mast cell histochemistry in murine skin","volume":"287","author":"Botchkarev","year":"1995","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.tips.2021.02.001_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002002","article-title":"Macrophages contribute to the cyclic activation of adult hair follicle stem cells","volume":"12","author":"Castellana","year":"2014","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tips.2021.02.001_bb0340","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.stem.2019.01.011","article-title":"A subset of TREM2+ dermal macrophages secretes oncostatin M to maintain hair follicle stem cell quiescence and inhibit hair growth","volume":"24","author":"Wang","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tips.2021.02.001_bb0345","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1038\/jid.2013.17","article-title":"Loss of \u03b3\u03b4 T cells results in hair cycling defects","volume":"133","author":"Kloepper","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0350","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/exd.14070","article-title":"Immune cell regulation of the hair cycle","volume":"29","author":"Wang","year":"2020","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0355","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bcp.2019.03.022","article-title":"Modulation of innate immunity by cyclosporine A","volume":"163","author":"Liddicoat","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2021.02.001_bb0360","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/j.jid.2019.04.026","article-title":"Human perifollicular macrophages undergo apoptosis, express Wnt Ligands, and switch their polarization during catagen","volume":"139","author":"Hardman","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tips.2021.02.001_bb0365","first-page":"564","article-title":"Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma","volume":"147","author":"Qu","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tips.2021.02.001_bb0370","doi-asserted-by":"crossref","first-page":"11210","DOI":"10.1096\/fj.201900797R","article-title":"Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis","volume":"33","author":"Forster","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2021.02.001_bb0375","first-page":"719","article-title":"Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone","volume":"144","author":"Paus","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tips.2021.02.001_bb0380","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad8996","article-title":"Chronic skin inflammation leads to bone loss by IL-17\u2013mediated inhibition of Wnt signaling in osteoblasts","volume":"8","author":"Ulu\u00e7kan","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2021.02.001_bb0385","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2337\/db14-1111","article-title":"High levels of pigment epithelium\u2013derived factor in diabetes impair wound healing through suppression of Wnt signaling","volume":"64","author":"Qi","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.tips.2021.02.001_bb0390","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.stemcr.2019.12.006","article-title":"SFRP1 in skin tumor initiation and cancer stem cell regulation with potential implications in epithelial cancers","volume":"14","author":"Sunkara","year":"2020","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.tips.2021.02.001_bb0395","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.tips.2018.03.008","article-title":"Targeting Wnt\/\u03b2-catenin signaling for cancer immunotherapy","volume":"39","author":"Wang","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2021.02.001_bb0400","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1164\/rccm.200910-1560OC","article-title":"Activation of the WNT\/\u03b2-catenin pathway attenuates experimental emphysema","volume":"183","author":"Kneidinger","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614721000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T09:10:40Z","timestamp":1759050640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614721000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0165614721000298"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2021.02.001","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond the NFAT Horizon: From Cyclosporine A-Induced Adverse Skin Effects to Novel Therapeutics","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2021.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}